ReviewCells2019

Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC.

Vera Kloten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.